Skip to main content
SpringerLink
Log in

Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 02 March 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Datta HK, Vila J, Tuck SP (2021) Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene. Osteoporos Int 32:2105–2109

    Article  CAS  Google Scholar 

  2. Bruford EA, Braschi B, Denny P, Jones TEM, Seal RL, Tweedie S (2020) Guidelines for human gene nomenclature. Nat Genet 52:754–758

    Article  CAS  Google Scholar 

  3. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux A-F, Smith T, Antonarakis SE, Taschner PEM (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37:564–569

    Article  Google Scholar 

  4. Freeman PJ, Hart RK, Gretton LJ, Brookes AJ, Dalgleish R (2018) VariantValidator: accurate validation, mapping, and formatting of variation descriptions. Hum Mutat 39:61–68

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Genetics and Genome Biology, University of Leicester, University Road, Leicester, LE1 7RH, UK

    Raymond Dalgleish

Authors
  1. Raymond Dalgleish
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond Dalgleish.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalgleish, R. Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene. Osteoporos Int 33, 1403–1404 (2022). https://doi.org/10.1007/s00198-022-06334-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-022-06334-w

Search

Navigation